Facts and reflections on COVID-19 and anti-hypertensives drugs.
Drug Discov Ther
; 14(2): 105-106, 2020 May 06.
Article
in English
| MEDLINE | ID: covidwho-15169
ABSTRACT
Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Hypertension
/
Antihypertensive Agents
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Drug Discov Ther
Year:
2020
Document Type:
Article
Affiliation country:
Ddt.2020.01017
Similar
MEDLINE
...
LILACS
LIS